777 related articles for article (PubMed ID: 34616741)
1. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities.
Claridge B; Lozano J; Poh QH; Greening DW
Front Cell Dev Biol; 2021; 9():734720. PubMed ID: 34616741
[TBL] [Abstract][Full Text] [Related]
2. Prospective applications of extracellular vesicle-based therapies in regenerative medicine: implications for the use of dental stem cell-derived extracellular vesicles.
Wang W; Xu Z; Liu M; Cai M; Liu X
Front Bioeng Biotechnol; 2023; 11():1278124. PubMed ID: 37936823
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging-guided extracellular vesicle-based drug delivery for precise cancer management: Current status and future perspectives.
Cheng Z; Shang J; Wang H; Yu L; Yuan Z; Zhang Y; Du Y; Tian J
J Control Release; 2023 Oct; 362():97-120. PubMed ID: 37625599
[TBL] [Abstract][Full Text] [Related]
4. Native and bioengineered extracellular vesicles for cardiovascular therapeutics.
de Abreu RC; Fernandes H; da Costa Martins PA; Sahoo S; Emanueli C; Ferreira L
Nat Rev Cardiol; 2020 Nov; 17(11):685-697. PubMed ID: 32483304
[TBL] [Abstract][Full Text] [Related]
5. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
[TBL] [Abstract][Full Text] [Related]
6. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
Nasiri Kenari A; Cheng L; Hill AF
Methods; 2020 May; 177():103-113. PubMed ID: 31917274
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy.
Tang Y; Liu X; Sun M; Xiong S; Xiao N; Li J; He X; Xie J
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514088
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicle therapeutics for liver disease.
Borrelli DA; Yankson K; Shukla N; Vilanilam G; Ticer T; Wolfram J
J Control Release; 2018 Mar; 273():86-98. PubMed ID: 29373816
[TBL] [Abstract][Full Text] [Related]
9. Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges.
Ullah M; Qiao Y; Concepcion W; Thakor AS
Stem Cell Res Ther; 2019 Nov; 10(1):347. PubMed ID: 31771657
[TBL] [Abstract][Full Text] [Related]
10. Emerging strategies for labeling and tracking of extracellular vesicles.
Li YJ; Wu JY; Wang JM; Hu XB; Xiang DX
J Control Release; 2020 Dec; 328():141-159. PubMed ID: 32882270
[TBL] [Abstract][Full Text] [Related]
11. Engineered Extracellular Vesicles: Tailored-Made Nanomaterials for Medical Applications.
Man K; Brunet MY; Jones MC; Cox SC
Nanomaterials (Basel); 2020 Sep; 10(9):. PubMed ID: 32942556
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles and exosome-like nanovesicles as pioneering oral drug delivery systems.
Mondal J; Pillarisetti S; Junnuthula V; Surwase SS; Hwang SR; Park IK; Lee YK
Front Bioeng Biotechnol; 2023; 11():1307878. PubMed ID: 38260737
[TBL] [Abstract][Full Text] [Related]
13. Before Translating Extracellular Vesicles into Personalized Diagnostics and Therapeutics: What We Could Do.
Cheng CA
Mol Pharm; 2024 Jun; 21(6):2625-2636. PubMed ID: 38771015
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agents.
Takahashi Y; Takakura Y
Pharmacol Ther; 2023 Feb; 242():108352. PubMed ID: 36702209
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Vesicle- and Extracellular Vesicle Mimetics-Based Drug Delivery Systems: New Perspectives, Challenges, and Clinical Developments.
Gangadaran P; Ahn BC
Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32403320
[TBL] [Abstract][Full Text] [Related]
16. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
[TBL] [Abstract][Full Text] [Related]
17. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
[TBL] [Abstract][Full Text] [Related]
18. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
19. From Promise to Reality: Bioengineering Strategies to Enhance the Therapeutic Potential of Extracellular Vesicles.
de Almeida Fuzeta M; Gonçalves PP; Fernandes-Platzgummer A; Cabral JMS; Bernardes N; da Silva CL
Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354586
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications.
Sharma S; Masud MK; Kaneti YV; Rewatkar P; Koradia A; Hossain MSA; Yamauchi Y; Popat A; Salomon C
Small; 2021 Oct; 17(42):e2102220. PubMed ID: 34216426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
